相关实验视频
Updated: Jan 13, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
通过计算方法发现用于癌症治疗的预测生物标志物
Xin Wang1, Julia Nguyen1,2, Kristen Nader3,4
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Nature reviews. Clinical oncology
|January 6, 2026
概括
鉴定癌症治疗个性化的有效生物标志物仍然具有挑战性. 包括机器学习在内的计算方法为发现预测生物标志物和优化精密瘤学治疗选择提供了有希望的途径.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 精准瘤学旨在使用预测生物标志物个性化癌症治疗.
- 对于大多数癌症疗法和组合来说,确定强大的生物标志物仍然是一个重大挑战.
- 现有的生物标志物往往缺乏可重现性和临床适用性,需要结合预测型.
研究的目的:
- 审查计算方法在癌症治疗预测生物标志物发现中的应用.
- 突出这一快速发展的领域的进展,挑战和未来的机遇.
- 探索机器学习和人工智能如何增强生物标志物的识别和应用.
主要方法:
- 对生物标志物发现中的计算方法的当前文献的综述.
- 机器学习和人工智能应用在预测治疗反应方面的分析.
- 检查预测药物组合疗效和协同效应的方法.
主要成果:
- 计算方法可以在各种临床和临床前数据中识别预测模式.
- 机器学习和人工智能在预测个体患者治疗反应方面显示出潜力.
- 这些方法可以帮助预测组合疗法的疗效和协同作用.
结论:
- 计算方法对于在精密瘤学中推进预测生物标志物发现至关重要.
- 克服可复制性和强度方面的挑战是临床翻译的关键.
- 未来的机遇在于整合各种数据类型和先进的AI模型,以实现个性化癌症护理.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.1K
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
893
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K